NLRP3 and hyperuricemia: Inhibiting the expression of NLRP3 inflammasome-related pathway proteins can effectively alleviate the uric acid nephropathy resulting from elevated uric acid levels and is a feasible strategy in preventing and treating the uric acid nephropathy caused by hyperuricemia [51].